Found: 22
Select item for more details and to access through your institution.
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3403, doi. 10.3390/cancers12113403
- By:
- Publication type:
- Article
Low-Grade Serous Carcinoma of the Ovary.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 7, p. 650
- By:
- Publication type:
- Article
Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
- Published in:
- 2020
- By:
- Publication type:
- journal article
BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 548, doi. 10.1002/cncr.27782
- By:
- Publication type:
- Article
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 15, p. 3703, doi. 10.1002/cncr.26655
- By:
- Publication type:
- Article
Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-54796-6
- By:
- Publication type:
- Article
BRAF<sup>V</sup><sup>600E</sup> mutations and immunohistochemical expression of VE1 protein in low‐grade serous neoplasms of the ovary.
- Published in:
- Histopathology, 2018, v. 73, n. 3, p. 438, doi. 10.1111/his.13651
- By:
- Publication type:
- Article
Redefining the Standard of Care for Low-Grade Serous Ovarian Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, p. 205
- By:
- Publication type:
- Article
Redefining the Standard of Care for Low-Grade Serous Ovarian Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, p. 205
- By:
- Publication type:
- Article
The highs and lows of serous ovarian cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 17, p. 2613, doi. 10.1002/cncr.34903
- By:
- Publication type:
- Article
Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 13, p. 2004, doi. 10.1002/cncr.34753
- By:
- Publication type:
- Article
Beyond the estrogen receptor: In search of predictive biomarkers for low‐grade serous ovarian cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 9, p. 1305, doi. 10.1002/cncr.34658
- By:
- Publication type:
- Article
Barriers and facilitators to screen for and address social needs in primary care practices in Maryland: a qualitative study.
- Published in:
- Frontiers in Health Services, 2024, p. 1, doi. 10.3389/frhs.2024.1380589
- By:
- Publication type:
- Article
Association of Participation in the Maryland Primary Care Program With COVID-19 Outcomes Among Medicare Beneficiaries.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2249791, doi. 10.1001/jamanetworkopen.2022.49791
- By:
- Publication type:
- Article
Mutations in <i>ap1b1</i> Cause Mistargeting of the Na<sup>+</sup>/K<sup>+</sup>-ATPase Pump in Sensory Hair Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060866
- By:
- Publication type:
- Article
Understanding social needs screening and demographic data collection in primary care practices serving Maryland Medicare patients.
- Published in:
- BMC Health Services Research, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12913-024-10948-7
- By:
- Publication type:
- Article
Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2294, doi. 10.1007/s10637-011-9765-7
- By:
- Publication type:
- Article
Erratum to: Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- Correction notice
Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04618-5
- By:
- Publication type:
- Article
Targeted Therapies for Treatment of Recurrent Ovarian Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2014, v. 12, n. 3, p. 158
- By:
- Publication type:
- Article
Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 11, p. 1549, doi. 10.1007/s11912-022-01315-y
- By:
- Publication type:
- Article